Deepika Jalota
2023
In 2023, Deepika Jalota earned a total compensation of $1.1M as Chief Development Officer at PMV Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $172,000 |
|---|---|
| Option Awards | $503,300 |
| Salary | $421,898 |
| Total | $1,097,198 |
Jalota received $503.3K in option awards, accounting for 46% of the total pay in 2023.
Jalota also received $172K in non-equity incentive plan and $421.9K in salary.
Rankings
In 2023, Deepika Jalota's compensation ranked 1,115th out of 3,006 executives tracked by ExecPay. In other words, Jalota earned more than 62.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,115 out of 3,006 | 63rd |
Division Manufacturing | 662 out of 1,650 | 60th |
Major group Chemicals And Allied Products | 451 out of 918 | 51st |
Industry group Drugs | 440 out of 881 | 50th |
Industry Pharmaceutical Preparations | 302 out of 637 | 53rd |
Source: SEC filing on April 24, 2024.
Jalota's colleagues
We found two more compensation records of executives who worked with Deepika Jalota at PMV Pharmaceuticals in 2023.